Skip Ribbon Commands
Skip to main content
Dr Kaavya Narasimhalu

Dr Narasimhalu Kaavya

​MD, PhD, MRCP, MMed (Internal Medicine)


National Neuroscience Institute

Specialty: Neurology, Neurology, Neuroscience

Sub-specialties: Neurogenetics, Stroke, General Neurology

Conditions Treated by this Doctor:

Clinical Appointments

  • Institution Lead (SGH) SingHealth Duke-NUS Genomic Medicine Centre
  • Consultant Department of Neurology National Neuroscience InstituteNational Neuroscience Institute
  • Consultant Neurology Singapore General HospitalSingapore General Hospital
  • Consultant Neuroscience Sengkang General HospitalSengkang General Hospital


​Dr Kaavya Narasimhalu is Consultant, Department of Neurology, at the National Neuroscience Institute (SGH Campus).


​Duke-NUS Graduate Medical School, MD, 2012
National University of Singapore, PhD, 2012
Karolinska Institutet, PhD, 2011
Washington University in St Louis, BA, 2005

Professional Appointments and Committee Memberships

  • Consultant, Department of Neurology, National Neuroscience Institute (SGH Campus)
  • ​Adjunct Research Fellow, Duke-NUS
  • Clinical Instructor, Yong Loo Lin School of Medicine, NUS
  • Clinical Instructor, Duke-NUS
  • Member, American Association of Neurology
  • Member, Vas-Cog Society


  • ​Outstanding Senior Resident, 2018
  • Outstanding Senior Resident, 2016
  • Best Oral Abstract, Neurocognitive Symposium, 2013
  • AAN (American Association of Neurology), 2011 International Scholarship Award
  • VAS-COG congress, 2007 Fellowship

Research Interests

  • Post stroke cognitive impairment


  • ​Alhamid SM, Lee DX, Wong HM, Chuah MB, Wong YJ, Narasimhalu K, Tan TT, Low SY “Implementing electronic handovers: interventions to improve safety, efficacy, and sustainability”Int J Qual Health 2016
  • Chan JYS, Narasimhalu K, Goh O, Xin XH, Wong TY, Thumboo J, Phua GC “Resident research: why some do and other’s don’t” 2017 SMJ
  • Kandiah N, Zainal NH, Narasimhalu K, Chander RJ, Ng A, Mak E, Au WL, Sitoh YY, Nadkami N, Tan CSL “Hippocampal volume and white matter disease in the prediction of dementia in Parkinson’s disease” Parkinonism & Related Disorders Nov 2014
  • Narasimhalu K, Lu M, de Silva DA, Wong MC, Chang HM, Chen CPL “Elevated platlet derived growth factor AB/BB is associated with a lower risk of recurrent vascular events in stroke patients.” International Journal of Stroke Sep 2015
  • Ng A, Chew I, Narasimhalu K, Kandiah N “Effectiveness of Montreal Cognitive Assessment for the diagnosis of mild cognitive impairment and mild Alzheimer’s Disease in Singapore” SMJ 2013 54(11) 616-9
  • Chin R, Ng A, Narasimhalu K, Kandiah N “Utility of the AD8 as a Self-Rating Tool for Cognitive Impairment in an Asian Population” Alzheimers Dis Other Demen. 2013 28(3):284-8
  • Narasimhalu K, Wiryasaputra L, Sitoh YY, Kandiah N “Post stroke subjective cognitive impairment is associated with acute lacunar infarcts in the basal ganglia” Eur J Neur 2013 20(3) 547-551
  • Narasimhalu K, Lee JHQ, Leong YL, de Silva D, Wong MC, Chang HM, Chen C “Inflammatory markers and their association with cognitive decline” Int J Stroke Mar 2013
  • Tan SYM, Narasimhalu K, Ong S “Letting the cat out of the bag: Shifting practices of cancer disclosure in Singapore” Singapore Med J 2012; 53(5): 344–348
  • Kandiah N, Wiryasaputra L, Narasimhalu K, Chua EV, Sitoh YY  “Frontal Subcortical Ischemia is crucial for post stroke cognitive impairment” J Neurol Sci 2011;309(1-2):92-5
  • Gibbons LE, Crane PK, Mehta KM, Pedraza O, Tang Y, Manly JJ, Narasimhalu K, Teresi J, Jones RN, Mungas D.  Multiple, correlated covariates associated with differential item functioning (DIF): Accounting for language DIF when education levels differ across languages.  Ageing Research (published online 28th April 2011)
  • Narasimhalu K, Ang S, de Silva DA, Wong MC, Chang HM, Auchus AP, Chen CP “The prognostic effects of post stroke CIND and domain specific cognitive impairments in non-disabled ischemic stroke patients” Stroke. 2011;42(4):883-888
  • Narasimhalu K, Effendy S, Sim CH, Lee J, Chen I, Hia SB, Xue HL, Corrales MP, Chang HM, Wong MC, Chen CP, Tan EK “A randomized controlled trial of Rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease” Acta Neurol Scand 2010: 121: 217-224
  • Narasimhalu K, Ang S, Auchus AP, Chang HM, Wong MC, Chen CP “Severity of Cognitive Impairment without dementia (CIND) predicts for incidence of dementia after stroke.” Neurology 2009; 73: 1866-1872
  • Kandiah N, Narasimhalu K, Chen CP “Differences exist in the cognitive profile of mild Alzheimer’s disease and subcortial ischemic vascular dementia” Dement Geriatr Cogn Disord 2009;27:399-403
  • Kandiah N, Narasimhalu K, Lau PN, Seah SH, Au WL, Tan LC.  “Cognitive decline in early Parkinson’s disease” Mov Disords 2009 Mar 15;24(4): 605-8
  • Crane PK, Narasimhalu K, Gibbons LE, Pedraza O, Mehta KM, Tang Y, Manly JJ, Reed BR, Mungas DM.  “Composite scores for executive function items: Demographic heterogeneity and relationships with quantitative magnetic resonance imaging” J Int Neuropsychol Soc. 2008 Sep;14(5):746-59.
  • Crane P, Narasimhalu K, Gibbons LE, Mungas DM, Haneuse S, Larson EB, Kuller L, Hall K, van Belle G (2008) “Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline” J Clin Epi  2008 Oct; 61(10): 1018-27
  • Narasimhalu K, Lee J, Auchus AP, Chen CP “Improving Detection of Dementia in Asian Patients with Low Education: Combining the Mini-Mental State Examination (MMSE) and the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)” Dementia and Geriatric Cognitive Disorders Nov 19; 25(1): 17-22
  • Crane P, Gibbons L, Ocepek-Welikson K, Cook K, Cella D, Narasimhalu K, Hays RD, Teresi JA “A comparison of three sets of criteria for determining the presence of differential item functioning using ordinal logistic regression” Qual Life Res. 2007;16 Suppl 1:69-84.
  • Crane P, Gibbons L, Narasimhalu K, Lai JS, Cella D “Rapid Detection of Differential Item Functioning in Assessments of Health-Related Quality of Life: The Functional Assessment of Cancer Therapy” Qual Life Res Feb 16(1) 101-14

Research Trials